""	"Name"	"Genes (tot)"	"Stat (dist.dir.up)"	"p (dist.dir.up)"	"p adj (dist.dir.up)"	"Stat (dist.dir.dn)"	"p (dist.dir.dn)"	"p adj (dist.dir.dn)"	"Stat (non-dir.)"	"p (non-dir.)"	"p adj (non-dir.)"	"Genes (up)"	"Stat (mix.dir.up)"	"p (mix.dir.up)"	"p adj (mix.dir.up)"	"Genes (down)"	"Stat (mix.dir.dn)"	"p (mix.dir.dn)"	"p adj (mix.dir.dn)"
"1"	"ABC transporters"	11	-0.094315	0.58034	0.95057	0.094315	0.41966	0.99471	-15.275	0.88335	0.99974	2	-2.3897	0.18918	0.72436	9	-15.76	0.96438	0.99064
"2"	"AGE-RAGE signaling pathway in diabetic complications"	39	0.63979	0.00013063	0.0099603	-0.63979	0.99987	1	-21.436	0.40952	0.78556	28	-17.052	0.20099	0.72648	11	-13.157	0.71792	0.88041
"3"	"AMPK signaling pathway"	56	-0.11378	0.45654	0.95057	0.11378	0.54346	0.99471	-24.684	0.28614	0.6786	26	-18.841	0.51331	0.99951	30	-16.185	0.20883	0.54195
"4"	"Acute myeloid leukemia"	28	-0.2088	0.71235	0.96956	0.2088	0.28765	0.99471	-22.052	0.8444	0.99974	15	-20.134	0.96549	0.99951	13	-10.737	0.28404	0.58528
"5"	"Adherens junction"	32	0.14992	0.13806	0.6478	-0.14992	0.86194	1	-17.145	0.18871	0.56427	14	-11.437	0.23847	0.78127	18	-12.773	0.32346	0.61396
"6"	"Adipocytokine signaling pathway"	31	0.36419	0.015274	0.2588	-0.36419	0.98473	1	-22.22	0.81294	0.99974	18	-14.699	0.35655	0.89417	13	-17.016	0.92299	0.97716
"7"	"Adrenergic signaling in cardiomyocytes"	57	-0.064145	0.35694	0.95057	0.064145	0.64306	0.99471	-21.814	0.063186	0.35124	31	-13.504	0.013272	0.32181	26	-17.553	0.55295	0.78295
"8"	"African trypanosomiasis"	14	0.23187	0.077633	0.57751	-0.23187	0.92237	1	-9.9862	0.1571	0.51809	5	-2.5959	0.041298	0.40546	9	-10.52	0.55446	0.78295
"9"	"Alanine, aspartate and glutamate metabolism"	16	0.65154	0.00054258	0.027581	-0.65154	0.99946	1	-9.4562	0.073688	0.36752	11	-7.0806	0.050836	0.46029	5	-6.4136	0.34647	0.62957
"10"	"Alcoholism"	29	-0.33124	0.85864	1	0.33124	0.14136	0.84134	-16.722	0.22754	0.62521	14	-16.832	0.82465	0.99951	15	-6.9894	0.021805	0.38113
"11"	"Aldosterone synthesis and secretion"	24	-0.45864	0.9521	1	0.45864	0.0479	0.52381	-14.999	0.24826	0.65949	10	-7.2824	0.078773	0.50806	14	-13.483	0.61501	0.82193
"12"	"Aldosterone-regulated sodium reabsorption"	16	-0.5455	0.98394	1	0.5455	0.016057	0.27207	-12.997	0.37322	0.74192	9	-13.305	0.77515	0.99951	7	-4.564	0.081251	0.42601
"13"	"Allograft rejection"	4	0.28508	0.068134	0.53284	-0.28508	0.93187	1	-9.3909	0.75469	0.99974	3	-6.1039	0.47233	0.98978	1	-8.2095	0.93587	0.97716
"14"	"Alzheimer disease"	113	-0.40341	0.82929	1	0.40341	0.17071	0.84709	-25.011	2.5592e-05	0.0026018	37	-15.808	0.015529	0.32181	76	-19.468	0.00071469	0.070992
"15"	"Amino sugar and nucleotide sugar metabolism"	27	0.074304	0.21563	0.78912	-0.074304	0.78437	1	-13.077	0.043365	0.33913	14	-11.449	0.23959	0.78127	13	-6.9647	0.038359	0.38113
"16"	"Aminoacyl-tRNA biosynthesis"	21	-0.042595	0.42385	0.95057	0.042595	0.57615	0.99471	-14.27	0.27259	0.67763	11	-10.484	0.27616	0.78815	10	-9.6841	0.37066	0.646
"17"	"Amoebiasis"	42	0.47628	0.0030282	0.09236	-0.47628	0.99697	1	-19.028	0.11454	0.4537	20	-13.331	0.15168	0.6818	22	-13.581	0.22094	0.54195
"18"	"Amphetamine addiction"	20	-0.092962	0.51826	0.95057	0.092962	0.48174	0.99471	-11.442	0.074709	0.36752	10	-9.1415	0.19799	0.72436	10	-7.0404	0.12237	0.48934
"19"	"Amyotrophic lateral sclerosis (ALS)"	21	-0.41702	0.93839	1	0.41702	0.061608	0.56941	-11.1	0.056473	0.35124	6	-6.8778	0.25292	0.78815	15	-8.7838	0.076178	0.41693
"20"	"Antigen processing and presentation"	24	-0.15554	0.62176	0.95057	0.15554	0.37824	0.99471	-14.398	0.19132	0.56653	11	-11.233	0.35767	0.89417	13	-9.2303	0.14691	0.49542
"21"	"Apelin signaling pathway"	54	-0.079136	0.39618	0.95057	0.079136	0.60382	0.99471	-25.081	0.39018	0.76131	26	-19.125	0.54877	0.99951	28	-16.401	0.33431	0.61582
"22"	"Apoptosis"	49	0.0047395	0.28258	0.92515	-0.0047395	0.71742	1	-28.542	0.88575	0.99974	24	-25.258	0.98504	0.99951	25	-15.212	0.30069	0.59453
"23"	"Arachidonic acid metabolism"	15	-0.14151	0.61839	0.95057	0.14151	0.38161	0.99471	-11.893	0.28014	0.67763	6	-3.4978	0.04325	0.40546	9	-12.498	0.7782	0.90234
"24"	"Arginine and proline metabolism"	27	0.24206	0.059667	0.51995	-0.24206	0.94033	1	-11.704	0.015474	0.2484	17	-9.5808	0.039137	0.40546	10	-6.7393	0.10418	0.48934
"25"	"Arginine biosynthesis"	11	0.381	0.023322	0.32333	-0.381	0.97668	1	-8.5469	0.16341	0.51916	8	-8.0638	0.2195	0.7657	3	-3.1978	0.1884	0.53695
"26"	"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"	36	0.13838	0.1248	0.60692	-0.13838	0.8752	1	-18.443	0.19947	0.58499	19	-11.902	0.087416	0.50806	17	-14.256	0.55175	0.78295
"27"	"Ascorbate and aldarate metabolism"	6	0.59472	0.0023716	0.080371	-0.59472	0.99763	1	-5.3032	0.16137	0.51809	5	-2.1379	0.030457	0.40546	1	-8.2095	0.93587	0.97716
"28"	"Asthma"	2	0.013768	0.41705	0.95057	-0.013768	0.58295	0.99471	-7.3297	0.77612	0.99974	2	-7.3297	0.74487	0.99951	0			
"29"	"Autoimmune thyroid disease"	4	0.28508	0.068134	0.53284	-0.28508	0.93187	1	-9.3909	0.75469	0.99974	3	-6.1039	0.47233	0.98978	1	-8.2095	0.93587	0.97716
"30"	"Autophagy"	56	-0.18111	0.58367	0.95057	0.18111	0.41633	0.99471	-28.976	0.79056	0.99974	32	-26.978	0.97442	0.99951	24	-13.111	0.13708	0.48934
"31"	"Axon guidance"	55	-0.11591	0.47708	0.95057	0.11591	0.52292	0.99471	-27.638	0.67254	0.99974	26	-21.696	0.82362	0.99951	29	-17.519	0.39593	0.65702
"32"	"B cell receptor signaling pathway"	27	-0.18356	0.65446	0.95057	0.18356	0.34554	0.99471	-22.073	0.88511	0.99974	15	-20.036	0.96308	0.99951	12	-10.709	0.3836	0.65329
"33"	"Bacterial invasion of epithelial cells"	42	0.0021051	0.28816	0.92515	-0.0021051	0.71184	1	-21.621	0.35106	0.73845	20	-15.956	0.42648	0.96822	22	-14.66	0.33477	0.61582
"34"	"Basal cell carcinoma"	4	-0.028721	0.48558	0.95057	0.028721	0.51442	0.99471	-13.158	0.97011	0.99974	2	-11.61	0.97683	0.99951	2	-6.9979	0.74762	0.88761
"35"	"Basal transcription factors"	4	0.30601	0.056279	0.50486	-0.30601	0.94372	1	-9.109	0.72576	0.99974	4	-9.109	0.71083	0.99951	0			
"36"	"Base excision repair"	8	0.070334	0.29729	0.93458	-0.070334	0.70271	1	-16.491	0.98024	0.99974	4	-9.6906	0.76959	0.99951	4	-13.632	0.98818	0.99064
"37"	"Bile secretion"	15	-0.76951	0.99922	1	0.76951	0.00078011	0.029742	-11.628	0.25227	0.65949	4	-12.574	0.94931	0.99951	11	-5.9969	0.046429	0.39531
"38"	"Biosynthesis of unsaturated fatty acids"	11	-0.35732	0.92158	1	0.35732	0.078415	0.61325	-10.503	0.36361	0.74192	5	-9.8085	0.67091	0.99951	6	-5.2676	0.17543	0.52234
"39"	"Bladder cancer"	12	-0.072298	0.5169	0.95057	0.072298	0.4831	0.99471	-13.77	0.68458	0.99974	5	-12.835	0.91251	0.99951	7	-7.1812	0.28668	0.58528
"40"	"Breast cancer"	22	-0.079404	0.50145	0.95057	0.079404	0.49855	0.99471	-21.618	0.94395	0.99974	14	-22.019	0.99404	0.99951	8	-6.7203	0.191	0.53695
"41"	"Butanoate metabolism"	16	0.21762	0.09574	0.59594	-0.21762	0.90426	1	-12.109	0.27235	0.67763	10	-8.2666	0.13253	0.64128	6	-9.1015	0.61216	0.82193
"42"	"C-type lectin receptor signaling pathway"	33	0.16173	0.11018	0.60115	-0.16173	0.88982	1	-22.205	0.72383	0.99974	19	-16.733	0.5604	0.99951	14	-14.598	0.74354	0.88761
"43"	"Calcium signaling pathway"	51	-0.070009	0.38585	0.95057	0.070009	0.61415	0.99471	-20.173	0.059812	0.35124	25	-12.992	0.038188	0.40546	26	-15.514	0.30521	0.59768
"44"	"Carbohydrate digestion and absorption"	12	-0.25591	0.80092	1	0.25591	0.19908	0.86938	-8.6094	0.12481	0.45793	6	-10.36	0.66099	0.99951	6	-1.8156	0.021204	0.38113
"45"	"Cardiac muscle contraction"	41	-0.30901	0.80047	1	0.30901	0.19953	0.86938	-13.996	0.0037069	0.12562	11	-3.5522	0.0032876	0.19725	30	-14.211	0.074439	0.41693
"46"	"Cell adhesion molecules (CAMs)"	24	-0.30102	0.83164	1	0.30102	0.16836	0.84709	-23.693	0.98281	0.99974	7	-10.914	0.65311	0.99951	17	-21.148	0.99064	0.99064
"47"	"Cell cycle"	32	0.1408	0.14704	0.66435	-0.1408	0.85296	1	-28.928	0.99817	0.99974	24	-26.728	0.99563	0.99951	8	-11.562	0.75853	0.88993
"48"	"Cellular senescence"	49	-0.0025339	0.29356	0.93268	0.0025339	0.70644	1	-21.848	0.16852	0.51917	27	-18.034	0.35708	0.89417	22	-12.627	0.142	0.48934
"49"	"Central carbon metabolism in cancer"	33	-0.11735	0.53436	0.95057	0.11735	0.46564	0.99471	-17.584	0.18119	0.55216	13	-14.631	0.66648	0.99951	20	-10.791	0.070776	0.41693
"50"	"Chagas disease (American trypanosomiasis)"	33	-0.14961	0.59402	0.95057	0.14961	0.40598	0.99471	-23.621	0.85437	0.99974	17	-19.008	0.87753	0.99951	16	-14.33	0.59441	0.81628
"51"	"Chemical carcinogenesis"	21	-0.28219	0.82047	1	0.28219	0.17953	0.85067	-9.6936	0.021699	0.26473	12	-10.233	0.19673	0.72436	9	-2.9914	0.01197	0.3567
"52"	"Chemokine signaling pathway"	50	-0.067686	0.37861	0.95057	0.067686	0.62139	0.99471	-29.168	0.92268	0.99974	31	-27.634	0.9824	0.99951	19	-12.018	0.17791	0.52234
"53"	"Cholesterol metabolism"	21	-0.10592	0.54027	0.95057	0.10592	0.45973	0.99471	-11.244	0.061725	0.35124	12	-7.4956	0.042888	0.40546	9	-8.5209	0.30888	0.5977
"54"	"Choline metabolism in cancer"	35	-0.1994	0.66641	0.95057	0.1994	0.33359	0.99471	-21.86	0.62215	0.99974	20	-21.702	0.95173	0.99951	15	-8.3327	0.057201	0.41279
"55"	"Cholinergic synapse"	30	-0.33256	0.86824	1	0.33256	0.13176	0.83522	-18.771	0.43762	0.81146	16	-18.139	0.84686	0.99951	14	-8.0861	0.072172	0.41693
"56"	"Chronic myeloid leukemia"	30	0.17121	0.11432	0.60115	-0.17121	0.88568	1	-24.433	0.95093	0.99974	21	-21.603	0.91771	0.99951	9	-11.609	0.68553	0.86197
"57"	"Circadian entrainment"	29	-0.27787	0.79648	1	0.27787	0.20352	0.87427	-16.638	0.21972	0.6205	13	-11.545	0.28636	0.78815	16	-11.994	0.30687	0.59768
"58"	"Circadian rhythm"	9	0.23139	0.098286	0.59954	-0.23139	0.90171	1	-9.1801	0.31969	0.71696	5	-3.112	0.057059	0.47549	4	-10.291	0.88469	0.97716
"59"	"Citrate cycle (TCA cycle)"	29	-0.47275	0.95766	1	0.47275	0.042345	0.52381	-10.887	0.005019	0.13916	12	-10.187	0.19271	0.72436	17	-5.6607	0.0041444	0.17643
"60"	"Cocaine addiction"	10	-0.27083	0.84458	1	0.27083	0.15542	0.84134	-8.6726	0.22617	0.62521	3	-6.3856	0.5066	0.99951	7	-6.1854	0.18936	0.53695
"61"	"Collecting duct acid secretion"	11	-0.94745	0.99998	1	0.94745	1.7542e-05	0.0017835	-5.8912	0.033027	0.31445	2	-3.3877	0.28436	0.78815	9	-4.916	0.049899	0.40189
"62"	"Colorectal cancer"	31	-0.094519	0.4984	0.95057	0.094519	0.5016	0.99471	-23.15	0.88225	0.99974	20	-23.66	0.98903	0.99951	11	-6.961	0.084321	0.43323
"63"	"Complement and coagulation cascades"	38	-0.17904	0.60245	0.95057	0.17904	0.39755	0.99471	-21.612	0.47476	0.85509	8	-11.961	0.67277	0.99951	30	-18.147	0.42804	0.69324
"64"	"Cortisol synthesis and secretion"	9	-0.1192	0.62724	0.95057	0.1192	0.37276	0.99471	-9.3973	0.34384	0.73336	4	-7.0591	0.46629	0.98978	5	-6.2939	0.33193	0.61582
"65"	"Cushing syndrome"	33	-0.19929	0.68132	0.95057	0.19929	0.31868	0.99471	-21.895	0.68916	0.99974	17	-18.345	0.8308	0.99951	16	-12.535	0.36976	0.646
"66"	"Cysteine and methionine metabolism"	29	0.088539	0.19666	0.76219	-0.088539	0.80334	1	-11.559	0.00904	0.19214	20	-9.8332	0.015626	0.32181	9	-6.0907	0.10166	0.48862
"67"	"Cytokine-cytokine receptor interaction"	3	0.23524	0.091665	0.59484	-0.23524	0.90834	1	-9.7555	0.88182	0.99974	2	-6.143	0.61358	0.99951	1	-8.2095	0.93587	0.97716
"68"	"Cytosolic DNA-sensing pathway"	11	0.11903	0.21733	0.78912	-0.11903	0.78267	1	-20.701	0.99838	0.99974	7	-16.178	0.97901	0.99951	4	-12.926	0.97924	0.99064
"69"	"D-Glutamine and D-glutamate metabolism"	3	0.071261	0.30336	0.93458	-0.071261	0.69664	1	-6.6594	0.57685	0.96581	3	-6.6594	0.53987	0.99951	0			
"70"	"DNA replication"	9	-0.066669	0.53284	0.95057	0.066669	0.46716	0.99471	-13.036	0.76197	0.99974	7	-14.024	0.9135	0.99951	2	-1.4156	0.12246	0.48934
"71"	"Dilated cardiomyopathy (DCM)"	45	0.33915	0.013656	0.2472	-0.33915	0.98634	1	-18.811	0.065888	0.35124	27	-12.316	0.01609	0.32181	18	-14.659	0.56459	0.78621
"72"	"Dopaminergic synapse"	46	-0.22933	0.6737	0.95057	0.22933	0.3263	0.99471	-20.149	0.12612	0.45793	24	-17.913	0.46694	0.98978	22	-10.426	0.038406	0.38113
"73"	"Drug metabolism"	38	-0.2686	0.74337	0.99008	0.2686	0.25663	0.99471	-18.415	0.1423	0.49321	21	-16.846	0.45536	0.98978	17	-8.8089	0.052031	0.40803
"74"	"ECM-receptor interaction"	38	0.55193	0.0015536	0.065958	-0.55193	0.99845	1	-17.213	0.073759	0.36752	16	-11.716	0.18283	0.7217	22	-12.631	0.14228	0.48934
"75"	"Endocrine and other factor-regulated calcium reabsorption"	21	-0.50026	0.973	1	0.50026	0.027004	0.37437	-15.193	0.37461	0.74192	7	-9.069	0.42821	0.96822	14	-12.195	0.44996	0.7209
"76"	"Endocytosis"	125	-0.12349	0.35654	0.95057	0.12349	0.64346	0.99471	-37.092	0.25036	0.65949	61	-25.236	0.12172	0.62921	64	-27.2	0.51947	0.77746
"77"	"Endometrial cancer"	20	-0.11179	0.55259	0.95057	0.11179	0.44741	0.99471	-17.874	0.74309	0.99974	9	-16.096	0.9507	0.99951	11	-9.5422	0.28675	0.58528
"78"	"Epithelial cell signaling in Helicobacter pylori infection"	30	-0.41676	0.93399	1	0.41676	0.066007	0.59212	-19.316	0.50686	0.8936	13	-13.608	0.54002	0.99951	17	-13.76	0.48808	0.75802
"79"	"Epstein-Barr virus infection"	74	-0.18604	0.56304	0.95057	0.18604	0.43696	0.99471	-37.764	0.99249	0.99974	36	-32.649	0.99951	0.99951	38	-20.921	0.53346	0.77926
"80"	"ErbB signaling pathway"	39	0.0013642	0.2773	0.92515	-0.0013642	0.7227	1	-24.608	0.79122	0.99974	27	-24.849	0.95997	0.99951	12	-7.0903	0.081486	0.42601
"81"	"Estrogen signaling pathway"	34	-0.11231	0.50957	0.95057	0.11231	0.49043	0.99471	-19.386	0.37224	0.74192	19	-17.079	0.60268	0.99951	15	-9.9647	0.14796	0.49542
"82"	"Ether lipid metabolism"	10	-0.15665	0.68513	0.95057	0.15665	0.31487	0.99471	-14.609	0.87905	0.99974	3	-9.829	0.85709	0.99951	7	-11.026	0.74584	0.88761
"83"	"Fanconi anemia pathway"	5	0.054078	0.3473	0.95057	-0.054078	0.6527	0.99471	-9.4068	0.67507	0.99974	3	-6.4743	0.51739	0.99951	2	-6.9442	0.74197	0.88761
"84"	"Fat digestion and absorption"	9	0.098549	0.24854	0.87131	-0.098549	0.75146	1	-8.7552	0.27467	0.67763	5	-6.1219	0.25113	0.78815	4	-6.2883	0.46956	0.74431
"85"	"Fatty acid biosynthesis"	7	0.21049	0.12735	0.60692	-0.21049	0.87265	1	-6.0806	0.13917	0.4879	4	-2.3764	0.060868	0.49352	3	-6.5442	0.55699	0.78295
"86"	"Fatty acid degradation"	32	0.34277	0.026665	0.32804	-0.34277	0.97334	1	-15.777	0.092956	0.41089	19	-9.3467	0.015577	0.32181	13	-13.453	0.61507	0.82193
"87"	"Fatty acid elongation"	15	-0.22355	0.7502	0.99483	0.22355	0.2498	0.99471	-9.585	0.092841	0.41089	8	-7.2565	0.15223	0.6818	7	-6.2734	0.19704	0.54195
"88"	"Fc epsilon RI signaling pathway"	27	-0.22607	0.72328	0.96956	0.22607	0.27672	0.99471	-19.262	0.61431	0.99974	16	-19.723	0.93296	0.99951	11	-6.3917	0.059848	0.41279
"89"	"Fc gamma R-mediated phagocytosis"	41	-0.24366	0.70713	0.96956	0.24366	0.29287	0.99471	-19.644	0.18285	0.55216	21	-15.813	0.33065	0.87783	20	-11.922	0.13535	0.48934
"90"	"Ferroptosis"	21	-0.36002	0.89929	1	0.36002	0.10071	0.71434	-11.112	0.056906	0.35124	12	-6.3952	0.019426	0.35306	9	-9.5897	0.43682	0.70364
"91"	"Fluid shear stress and atherosclerosis"	58	0.11869	0.10496	0.60115	-0.11869	0.89504	1	-28.57	0.71586	0.99974	39	-25.045	0.71458	0.99951	19	-14.035	0.39686	0.65702
"92"	"Focal adhesion"	101	0.42431	0.00173	0.065958	-0.42431	0.99827	1	-31.118	0.076188	0.36885	51	-25.942	0.43524	0.96855	50	-18.027	0.032741	0.38113
"93"	"Folate biosynthesis"	11	0.078951	0.27546	0.92515	-0.078951	0.72454	1	-5.0966	0.018102	0.25137	6	-1.8395	0.012916	0.32181	5	-5.5445	0.24717	0.54476
"94"	"FoxO signaling pathway"	42	0.13237	0.12317	0.60692	-0.13237	0.87683	1	-23.126	0.53742	0.92704	26	-19.32	0.57281	0.99951	16	-12.841	0.4071	0.66658
"95"	"Fructose and mannose metabolism"	21	-0.37446	0.91058	1	0.37446	0.089416	0.66362	-9.8425	0.024201	0.27338	6	-6.0268	0.17634	0.7217	15	-7.8341	0.040783	0.38113
"96"	"GABAergic synapse"	19	-0.32474	0.87464	1	0.32474	0.12536	0.83121	-11.996	0.12845	0.46093	8	-12.579	0.7393	0.99951	11	-5.0389	0.02371	0.38113
"97"	"Galactose metabolism"	15	0.37552	0.019938	0.32005	-0.37552	0.98006	1	-8.372	0.043364	0.33913	7	-5.1994	0.08283	0.50806	8	-6.6002	0.18054	0.52234
"98"	"Gap junction"	28	-0.11024	0.53379	0.95057	0.11024	0.46621	0.99471	-17.259	0.33219	0.72891	13	-13.257	0.49502	0.99951	15	-11.238	0.26472	0.56487
"99"	"Gastric acid secretion"	23	-0.79657	0.99969	1	0.79657	0.00031391	0.015957	-10.286	0.018956	0.25137	8	-6.6534	0.112	0.61093	15	-7.8774	0.042036	0.38113
"100"	"Gastric cancer"	29	-0.15062	0.59666	0.95057	0.15062	0.40334	0.99471	-25.369	0.97507	0.99974	17	-24.137	0.99705	0.99951	12	-10.709	0.38364	0.65329
"101"	"Glioma"	25	-0.054765	0.44294	0.95057	0.054765	0.55706	0.99471	-20.057	0.77038	0.99974	14	-16.843	0.8255	0.99951	11	-11.235	0.48839	0.75802
"102"	"Glucagon signaling pathway"	49	-0.34044	0.82957	1	0.34044	0.17043	0.84709	-23.106	0.29003	0.68045	17	-16.31	0.62781	0.99951	32	-16.704	0.21801	0.54195
"103"	"Glutamatergic synapse"	27	-0.3713	0.89611	1	0.3713	0.10389	0.71484	-14.247	0.09113	0.41089	11	-12.724	0.53667	0.99951	16	-7.9572	0.036745	0.38113
"104"	"Glutathione metabolism"	34	-0.16965	0.61073	0.95057	0.16965	0.38927	0.99471	-13.509	0.013516	0.22903	22	-12.528	0.069917	0.50806	12	-5.7752	0.036357	0.38113
"105"	"Glycerolipid metabolism"	20	0.0021834	0.34791	0.95057	-0.0021834	0.65209	0.99471	-11.041	0.057954	0.35124	10	-7.4429	0.086184	0.50806	10	-8.1719	0.20993	0.54195
"106"	"Glycerophospholipid metabolism"	29	-0.70014	0.99718	1	0.70014	0.0028166	0.061361	-21.081	0.73182	0.99974	12	-16.317	0.85741	0.99951	17	-13.825	0.49643	0.76256
"107"	"Glycine, serine and threonine metabolism"	17	0.19204	0.11193	0.60115	-0.19204	0.88807	1	-10.691	0.11276	0.45253	10	-8.5499	0.15186	0.6818	7	-6.4417	0.21225	0.54195
"108"	"Glycolysis / Gluconeogenesis"	47	-0.48217	0.9508	1	0.48217	0.049202	0.52381	-12.622	0.00012021	0.0085239	15	-7.1654	0.013289	0.32181	32	-10.391	0.0027665	0.16488
"109"	"Glycosaminoglycan degradation"	5	-0.0093156	0.45789	0.95057	0.0093156	0.54211	0.99471	-10.281	0.76404	0.99974	3	-7.4995	0.63925	0.99951	2	-7.0702	0.75513	0.88945
"110"	"Glycosphingolipid biosynthesis"	2	0.017881	0.41073	0.95057	-0.017881	0.58927	0.99471	-3.38	0.30723	0.69412	2	-3.38	0.28355	0.78815	0			
"111"	"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"	4	-0.062312	0.54754	0.95057	0.062312	0.45246	0.99471	-9.2279	0.73816	0.99974	1	-1.2234	0.21882	0.7657	3	-9.9492	0.88268	0.97716
"112"	"Glyoxylate and dicarboxylate metabolism"	23	0.12679	0.15247	0.66435	-0.12679	0.84753	1	-10.243	0.018354	0.25137	14	-7.7501	0.033246	0.40546	9	-6.709	0.14109	0.48934
"113"	"GnRH signaling pathway"	33	-0.016872	0.34973	0.95057	0.016872	0.65027	0.99471	-18.127	0.23147	0.63034	18	-14.526	0.33673	0.87842	15	-10.974	0.23721	0.54377
"114"	"Graft-versus-host disease"	4	0.28508	0.068134	0.53284	-0.28508	0.93187	1	-9.3909	0.75469	0.99974	3	-6.1039	0.47233	0.98978	1	-8.2095	0.93587	0.97716
"115"	"HIF-1 signaling pathway"	51	-0.15034	0.53565	0.95057	0.15034	0.46435	0.99471	-22.752	0.22487	0.62521	26	-19.742	0.62402	0.99951	25	-12.364	0.072668	0.41693
"116"	"Hedgehog signaling pathway"	9	0.060001	0.30804	0.93951	-0.060001	0.69196	1	-13.542	0.80727	0.99974	7	-14.1	0.91715	0.99951	2	-2.3489	0.19577	0.54195
"117"	"Hematopoietic cell lineage"	14	-0.12025	0.59166	0.95057	0.12025	0.40834	0.99471	-13.91	0.57949	0.96581	6	-8.9687	0.49342	0.99951	8	-10.634	0.6553	0.85275
"118"	"Hepatitis B"	53	0.25613	0.040366	0.39715	-0.25613	0.95963	1	-30.302	0.9278	0.99974	33	-24.873	0.87697	0.99951	20	-17.379	0.75092	0.888
"119"	"Hepatitis C"	50	-0.068906	0.38071	0.95057	0.068906	0.61929	0.99471	-29.764	0.94737	0.99974	30	-25.789	0.95424	0.99951	20	-15.475	0.52265	0.77746
"120"	"Hepatocellular carcinoma"	43	0.049658	0.2114	0.78632	-0.049658	0.7886	1	-25.166	0.73714	0.99974	30	-24.186	0.88312	0.99951	13	-9.0279	0.13261	0.48934
"121"	"Herpes simplex virus 1 infection"	59	0.28878	0.021357	0.32333	-0.28878	0.97864	1	-32.73	0.96508	0.99974	34	-25.096	0.84644	0.99951	25	-21.013	0.91615	0.97716
"122"	"Hippo signaling pathway"	34	0.15363	0.1212	0.60692	-0.15363	0.8788	1	-23.648	0.85104	0.99974	16	-15.422	0.58227	0.99951	18	-17.961	0.89426	0.97716
"123"	"Histidine metabolism"	10	0.25549	0.075518	0.57582	-0.25549	0.92448	1	-3.6025	0.0083553	0.19214	6	-2.5936	0.023036	0.35306	4	-2.5196	0.1008	0.48862
"124"	"Homologous recombination"	8	-0.23445	0.81594	1	0.23445	0.18406	0.85067	-8.296	0.29862	0.69	5	-9.3846	0.62339	0.99951	3	-1.4318	0.076951	0.41693
"125"	"Human T-cell leukemia virus 1 infection"	61	0.1049	0.12132	0.60692	-0.1049	0.87868	1	-30.858	0.87406	0.99974	30	-20.638	0.53657	0.99951	31	-22.983	0.91446	0.97716
"126"	"Human cytomegalovirus infection"	77	-0.49468	0.94882	1	0.49468	0.051185	0.52381	-35.231	0.90484	0.99974	36	-31.426	0.99815	0.99951	41	-18.834	0.18027	0.52234
"127"	"Human immunodeficiency virus 1 infection"	80	-0.26675	0.69407	0.95789	0.26675	0.30593	0.99471	-33.479	0.71483	0.99974	43	-30.004	0.96781	0.99951	37	-16.882	0.11387	0.48934
"128"	"Human papillomavirus infection"	110	0.0028076	0.18209	0.75049	-0.0028076	0.81791	1	-43.273	0.9763	0.99974	52	-35.73	0.99708	0.99951	58	-25.762	0.48485	0.75802
"129"	"Huntington disease"	113	-0.42172	0.85022	1	0.42172	0.14978	0.84134	-28.457	0.0016848	0.073408	40	-20.704	0.19626	0.72436	73	-20.08	0.0022292	0.16488
"130"	"Hypertrophic cardiomyopathy (HCM)"	48	0.40862	0.0065314	0.16601	-0.40862	0.99347	1	-20.644	0.12327	0.45793	29	-12.289	0.0071247	0.32181	19	-17.629	0.82069	0.93703
"131"	"IL-17 signaling pathway"	25	0.089234	0.21029	0.78632	-0.089234	0.78971	1	-23.71	0.96974	0.99974	18	-20.693	0.93179	0.99951	7	-11.625	0.80297	0.92746
"132"	"Inflammatory bowel disease (IBD)"	8	0.22071	0.1077	0.60115	-0.22071	0.8923	1	-11.584	0.69482	0.99974	6	-6.6727	0.23301	0.78127	2	-11.61	0.98533	0.99064
"133"	"Inflammatory mediator regulation of TRP channels"	29	-0.017078	0.35623	0.95057	0.017078	0.64377	0.99471	-18.147	0.38187	0.75142	16	-12.813	0.28255	0.78815	13	-12.889	0.54511	0.78295
"134"	"Influenza A"	56	0.26848	0.026888	0.32804	-0.26848	0.97311	1	-26.977	0.56704	0.96081	32	-22.307	0.67781	0.99951	24	-15.45	0.36017	0.64337
"135"	"Inositol phosphate metabolism"	24	-0.071076	0.47304	0.95057	0.071076	0.52696	0.99471	-19.67	0.79442	0.99974	13	-14.968	0.70498	0.99951	11	-12.782	0.67665	0.86197
"136"	"Insulin resistance"	53	0.35835	0.013778	0.2472	-0.35835	0.98622	1	-27.95	0.76308	0.99974	31	-19.444	0.34445	0.89082	22	-20.3	0.91343	0.97716
"137"	"Insulin secretion"	22	-0.64411	0.99402	1	0.64411	0.0059786	0.11397	-14.332	0.25515	0.65949	9	-8.9114	0.25664	0.78815	13	-11.229	0.33931	0.62033
"138"	"Insulin signaling pathway"	77	0.12936	0.09446	0.59594	-0.12936	0.90554	1	-33.996	0.82154	0.99974	40	-27.288	0.88541	0.99951	37	-20.67	0.52283	0.77746
"139"	"Intestinal immune network for IgA production"	2	0.013768	0.41705	0.95057	-0.013768	0.58295	0.99471	-7.3297	0.77612	0.99974	2	-7.3297	0.74487	0.99951	0			
"140"	"JAK-STAT signaling pathway"	18	0.052538	0.28044	0.92515	-0.052538	0.71956	1	-19.291	0.91862	0.99974	13	-16.958	0.88095	0.99951	5	-9.2581	0.70867	0.87629
"141"	"Kaposi sarcoma-associated herpesvirus infection"	59	-0.2593	0.70941	0.96956	0.2593	0.29059	0.99471	-30.775	0.88031	0.99974	29	-26.515	0.98443	0.99951	30	-17.089	0.30126	0.59453
"142"	"Legionellosis"	23	-0.13881	0.59978	0.95057	0.13881	0.40022	0.99471	-12.161	0.067944	0.35124	11	-7.8598	0.081038	0.50806	12	-9.3109	0.23557	0.54377
"143"	"Leishmaniasis"	15	-0.06647	0.48375	0.95057	0.06647	0.51625	0.99471	-16.227	0.79081	0.99974	9	-13.71	0.81217	0.99951	6	-8.867	0.58335	0.80855
"144"	"Leukocyte transendothelial migration"	50	-0.35863	0.84305	1	0.35863	0.15695	0.84134	-23.146	0.28701	0.6786	21	-17.512	0.53905	0.99951	29	-15.49	0.17987	0.52234
"145"	"Linoleic acid metabolism"	3	-0.15224	0.72479	0.96956	0.15224	0.27521	0.99471	-9.9492	0.89364	0.99974	0				3	-9.9492	0.88268	0.97716
"146"	"Long-term depression"	24	-0.33405	0.86616	1	0.33405	0.13384	0.83522	-14.111	0.1672	0.51917	10	-9.8271	0.26088	0.78815	14	-10.171	0.21682	0.54195
"147"	"Long-term potentiation"	29	-0.037497	0.39174	0.95057	0.037497	0.60826	0.99471	-14.701	0.083825	0.39199	15	-9.8451	0.083222	0.50806	14	-10.968	0.3001	0.59453
"148"	"Longevity regulating pathway"	44	0.1691	0.084502	0.59484	-0.1691	0.9155	1	-27.322	0.9035	0.99974	25	-22.036	0.86687	0.99951	19	-16.3	0.68508	0.86197
"149"	"Lysine degradation"	22	0.32085	0.037929	0.39715	-0.32085	0.96207	1	-12.013	0.084825	0.39199	12	-7.8379	0.053701	0.46029	10	-9.2329	0.31836	0.60933
"150"	"Lysosome"	41	-0.444	0.92778	1	0.444	0.07222	0.61121	-27.601	0.94449	0.99974	20	-22.352	0.96933	0.99951	21	-16.753	0.64294	0.84403
"151"	"MAPK signaling pathway"	80	0.035	0.17643	0.75049	-0.035	0.82357	1	-33.218	0.68578	0.99974	42	-23.386	0.40578	0.94634	38	-23.611	0.8421	0.95417
"152"	"Malaria"	13	0.34402	0.039073	0.39715	-0.34402	0.96093	1	-12.849	0.49668	0.88075	5	-4.9438	0.15228	0.6818	8	-12.47	0.8407	0.95417
"153"	"Mannose type O-glycan biosynthesis"	1	0	0.46621	0.95057	0	0.53379	0.99471	-8.2095	0.91818	0.99974	1	-8.2095	0.91873	0.99951	0			
"154"	"Maturity onset diabetes of the young"	1	0	0.46621	0.95057	0	0.53379	0.99471	-8.2095	0.91818	0.99974	0				1	-8.2095	0.93587	0.97716
"155"	"Measles"	40	0.13693	0.1267	0.60692	-0.13693	0.8733	1	-27.901	0.96041	0.99974	27	-24.68	0.95524	0.99951	13	-13.374	0.60546	0.82193
"156"	"Melanogenesis"	23	-0.18118	0.67606	0.95057	0.18118	0.32394	0.99471	-16.065	0.39189	0.76131	11	-13.697	0.65169	0.99951	12	-9.1273	0.21876	0.54195
"157"	"Melanoma"	14	-0.024066	0.41304	0.95057	0.024066	0.58696	0.99471	-16.876	0.8671	0.99974	7	-14.413	0.93105	0.99951	7	-9.453	0.56374	0.78621
"158"	"Metabolism of xenobiotics by cytochrome P450"	19	-0.088901	0.52516	0.95057	0.088901	0.47484	0.99471	-10.209	0.04549	0.34686	11	-8.4333	0.11077	0.61093	8	-5.8444	0.12317	0.48934
"159"	"MicroRNAs in cancer"	43	-0.338	0.8405	1	0.338	0.1595	0.84134	-29.868	0.98455	0.99974	24	-25.53	0.98792	0.99951	19	-16.24	0.67798	0.86197
"160"	"Mineral absorption"	12	-1.5167	1	1	1.5167	1.0408e-10	3.1744e-08	-5.6617	0.018608	0.25137	2	-1.5677	0.12776	0.63879	10	-5.501	0.04964	0.40189
"161"	"Mismatch repair"	7	-0.12471	0.65728	0.95057	0.12471	0.34272	0.99471	-11.201	0.73437	0.99974	5	-12.358	0.8873	0.99951	2	-1.4156	0.12246	0.48934
"162"	"Mitophagy"	33	0.15872	0.11286	0.60115	-0.15872	0.88714	1	-21.929	0.69295	0.99974	18	-13.557	0.23525	0.78127	15	-17.675	0.92989	0.97716
"163"	"Morphine addiction"	14	-0.41162	0.94515	1	0.41162	0.054847	0.53962	-11.384	0.28216	0.67763	6	-14.129	0.94347	0.99951	8	-2.8241	0.016082	0.36448
"164"	"Mucin type O-glycan biosynthesis"	1	-0.40745	0.97353	1	0.40745	0.026471	0.37437	-0.478	0.16013	0.51809	0				1	-0.478	0.17622	0.52234
"165"	"N-Glycan biosynthesis"	13	-0.011975	0.4231	0.95057	0.011975	0.5769	0.99471	-13.659	0.59635	0.98851	4	-5.4019	0.27347	0.78815	9	-12.815	0.807	0.92851
"166"	"NF-kappa B signaling pathway"	20	0.015022	0.32639	0.95057	-0.015022	0.67361	1	-22.744	0.98742	0.99974	12	-16.577	0.8751	0.99951	8	-15.66	0.97909	0.99064
"167"	"NOD-like receptor signaling pathway"	50	-0.043606	0.33794	0.95057	0.043606	0.66206	0.99471	-27.804	0.83487	0.99974	29	-22.101	0.76611	0.99951	21	-16.93	0.66366	0.85615
"168"	"Natural killer cell mediated cytotoxicity"	27	-0.014841	0.35287	0.95057	0.014841	0.64713	0.99471	-17.338	0.36963	0.74192	14	-14.058	0.53496	0.99951	13	-10.397	0.24862	0.54476
"169"	"Necroptosis"	58	-0.23387	0.64728	0.95057	0.23387	0.35272	0.99471	-25.814	0.37161	0.74192	33	-19.301	0.27417	0.78815	25	-17.143	0.54404	0.78295
"170"	"Neomycin, kanamycin and gentamicin biosynthesis"	2	0.90161	0.00010348	0.0099603	-0.90161	0.9999	1	-0.18953	0.06378	0.35124	1	0.99439	0.071337	0.50806	1	-1.2624	0.24787	0.54476
"171"	"Neuroactive ligand-receptor interaction"	9	-0.12179	0.63174	0.95057	0.12179	0.36826	0.99471	-10.165	0.43371	0.81146	3	-11.001	0.9229	0.99951	6	-4.6704	0.1308	0.48934
"172"	"Neurotrophin signaling pathway"	48	0.10516	0.14695	0.66435	-0.10516	0.85305	1	-26.619	0.75789	0.99974	30	-22.695	0.76694	0.99951	18	-14.169	0.50056	0.76495
"173"	"Nicotinate and nicotinamide metabolism"	18	-0.099694	0.55234	0.95057	0.099694	0.44766	0.99471	-17.757	0.81569	0.99974	8	-10.371	0.47974	0.99256	10	-14.548	0.88543	0.97716
"174"	"Nitrogen metabolism"	7	0.75647	0.00012915	0.0099603	-0.75647	0.99987	1	-3.2428	0.021085	0.26473	4	-0.83774	0.021269	0.35306	3	-3.9861	0.26049	0.5625
"175"	"Non-alcoholic fatty liver disease (NAFLD)"	96	0.0040118	0.19741	0.76219	-0.0040118	0.80259	1	-27.372	0.0094495	0.19214	40	-18.261	0.052782	0.46029	56	-20.406	0.060949	0.41279
"176"	"Non-homologous end-joining"	5	0.095657	0.28069	0.92515	-0.095657	0.71931	1	-7.0447	0.39614	0.7647	4	-6.5541	0.40424	0.94634	1	-2.6443	0.40394	0.66505
"177"	"Non-small cell lung cancer"	23	-0.060464	0.4505	0.95057	0.060464	0.5495	0.99471	-18.874	0.72609	0.99974	14	-18.642	0.93123	0.99951	9	-6.9205	0.15669	0.51356
"178"	"Notch signaling pathway"	6	0.0076593	0.40023	0.95057	-0.0076593	0.59977	0.99471	-17.644	0.99807	0.99974	5	-15.657	0.9864	0.99951	1	-8.2095	0.93587	0.97716
"179"	"Nucleotide excision repair"	11	0.12977	0.20305	0.77413	-0.12977	0.79695	1	-13.276	0.70758	0.99974	8	-11.303	0.59536	0.99951	3	-6.963	0.60715	0.82193
"180"	"Olfactory transduction"	11	-0.028795	0.4604	0.95057	0.028795	0.5396	0.99471	-13.517	0.73373	0.99974	6	-12.202	0.83813	0.99951	5	-6.6816	0.37985	0.65329
"181"	"One carbon pool by folate"	11	0.063129	0.30034	0.93458	-0.063129	0.69966	1	-12.448	0.60988	0.99974	8	-10.08	0.44354	0.97841	3	-7.375	0.65481	0.85275
"182"	"Oocyte meiosis"	41	-0.10967	0.47347	0.95057	0.10967	0.52653	0.99471	-18.498	0.10309	0.43072	20	-13.191	0.14135	0.67311	21	-12.974	0.20217	0.54195
"183"	"Osteoclast differentiation"	32	-0.19431	0.66124	0.95057	0.19431	0.33876	0.99471	-24.853	0.94477	0.99974	18	-20.787	0.93555	0.99951	14	-14.004	0.67773	0.86197
"184"	"Other glycan degradation"	6	0.058551	0.31716	0.95057	-0.058551	0.68284	1	-10.03	0.69018	0.99974	4	-4.0741	0.15454	0.6818	2	-11.61	0.98533	0.99064
"185"	"Other types of O-glycan biosynthesis"	4	-0.0348	0.49681	0.95057	0.0348	0.50319	0.99471	-6.7297	0.43899	0.81146	3	-7.0647	0.58853	0.99951	1	-1.2231	0.24394	0.54476
"186"	"Ovarian steroidogenesis"	9	-0.03024	0.46594	0.95057	0.03024	0.53406	0.99471	-13.542	0.80727	0.99974	4	-9.7351	0.77379	0.99951	5	-9.4614	0.73139	0.88761
"187"	"Oxidative phosphorylation"	93	-0.60898	0.98101	1	0.60898	0.018992	0.28962	-19.186	4.2837e-07	0.00013065	24	-9.0448	0.0025208	0.19725	69	-16.94	0.00015752	0.04694
"188"	"Oxytocin signaling pathway"	63	-0.10187	0.42152	0.95057	0.10187	0.57848	0.99471	-24.209	0.11657	0.45584	25	-11.804	0.015741	0.32181	38	-21.597	0.62363	0.82964
"189"	"PI3K-Akt signaling pathway"	101	0.15827	0.04682	0.43273	-0.15827	0.95318	1	-38.741	0.84558	0.99974	55	-34.651	0.98659	0.99951	46	-19.516	0.13449	0.48934
"190"	"PPAR signaling pathway"	35	0.093042	0.17893	0.75049	-0.093042	0.82107	1	-15.479	0.038942	0.32992	18	-9.7767	0.029191	0.40546	17	-12.151	0.29168	0.58731
"191"	"Pancreatic cancer"	31	0.12291	0.15213	0.66435	-0.12291	0.84787	1	-23.794	0.91806	0.99974	20	-20.03	0.86957	0.99951	11	-12.936	0.69394	0.86525
"192"	"Pancreatic secretion"	23	-0.66908	0.99749	1	0.66908	0.0025115	0.058923	-14.274	0.20252	0.5856	6	-6.0958	0.18194	0.7217	17	-12.981	0.38945	0.65702
"193"	"Pantothenate and CoA biosynthesis"	8	-0.084545	0.57753	0.95057	0.084545	0.42247	0.99471	-11.015	0.62935	0.99974	5	-12.036	0.86762	0.99951	3	-2.4494	0.13274	0.48934
"194"	"Parathyroid hormone synthesis, secretion and action"	23	-0.27324	0.81592	1	0.27324	0.18408	0.85067	-17.757	0.59983	0.98891	9	-15.364	0.92171	0.99951	14	-10.441	0.24345	0.54476
"195"	"Parkinson disease"	98	-0.23741	0.57828	0.95057	0.23741	0.42172	0.99471	-21.18	1.2102e-05	0.0018456	32	-11.987	0.0023468	0.19725	66	-17.462	0.00047552	0.070852
"196"	"Pathogenic Escherichia coli infection"	33	-0.13712	0.57109	0.95057	0.13712	0.42891	0.99471	-17.289	0.15697	0.51809	14	-13.186	0.42924	0.96822	19	-11.466	0.13468	0.48934
"197"	"Pathways in cancer"	140	0.045725	0.11029	0.60115	-0.045725	0.88971	1	-44.673	0.81695	0.99974	79	-40.405	0.99084	0.99951	61	-21.697	0.059775	0.41279
"198"	"Pentose and glucuronate interconversions"	7	0.16159	0.18043	0.75049	-0.16159	0.81957	1	-4.3963	0.049821	0.35124	4	-2.6283	0.070941	0.50806	3	-3.6804	0.23096	0.54195
"199"	"Pentose phosphate pathway"	22	-0.31461	0.8529	1	0.31461	0.1471	0.84134	-14.327	0.25466	0.65949	8	-9.7798	0.4067	0.94634	14	-10.567	0.2564	0.55772
"200"	"Peroxisome"	42	-0.29484	0.79107	1	0.29484	0.20893	0.87716	-23.177	0.54382	0.93182	10	-8.8761	0.17633	0.7217	32	-21.591	0.77802	0.90234
"201"	"Pertussis"	28	-0.30207	0.8438	1	0.30207	0.1562	0.84134	-16.573	0.26082	0.66336	9	-13.174	0.76239	0.99951	19	-11.052	0.10741	0.48934
"202"	"Phagosome"	59	-0.76337	0.99827	1	0.76337	0.0017343	0.048087	-20.207	0.011794	0.21397	18	-12.153	0.12374	0.62921	41	-16.187	0.038913	0.38113
"203"	"Phenylalanine metabolism"	6	0.015753	0.3866	0.95057	-0.015753	0.6134	0.99471	-7.3447	0.36418	0.74192	3	-6.6806	0.54244	0.99951	3	-3.7064	0.2334	0.54338
"204"	"Phenylalanine, tyrosine and tryptophan biosynthesis"	2	-0.024104	0.47604	0.95057	0.024104	0.52396	0.99471	-3.2742	0.29545	0.68788	0				2	-3.2742	0.28994	0.58731
"205"	"Phosphatidylinositol signaling system"	28	-0.1711	0.64743	0.95057	0.1711	0.35257	0.99471	-21.827	0.8276	0.99974	15	-16.407	0.74489	0.99951	13	-14.409	0.72464	0.88501
"206"	"Phospholipase D signaling pathway"	40	-0.20965	0.67451	0.95057	0.20965	0.32549	0.99471	-20.994	0.34161	0.73336	20	-18.827	0.76965	0.99951	20	-10.863	0.074017	0.41693
"207"	"Phosphonate and phosphinate metabolism"	2	-0.23852	0.78388	1	0.23852	0.21612	0.89076	-1.5591	0.13876	0.4879	1	-1.6977	0.26479	0.78815	1	-0.50714	0.17862	0.52234
"208"	"Phototransduction"	2	-0.010964	0.45545	0.95057	0.010964	0.54455	0.99471	-7.3928	0.7821	0.99974	1	-8.2095	0.91873	0.99951	1	-2.2454	0.35584	0.64266
"209"	"Platelet activation"	53	-0.078484	0.4012	0.95057	0.078484	0.5988	0.99471	-24.539	0.3588	0.74192	23	-17.946	0.50419	0.99951	30	-16.903	0.28088	0.58528
"210"	"Porphyrin and chlorophyll metabolism"	18	-0.42393	0.95057	1	0.42393	0.049433	0.52381	-9.6207	0.041279	0.33913	4	-6.813	0.43585	0.96855	14	-7.2672	0.042205	0.38113
"211"	"Primary bile acid biosynthesis"	6	-1.0771	1	1	1.0771	3.4234e-06	0.00052207	-4.5669	0.11119	0.45253	0				6	-4.5669	0.12394	0.48934
"212"	"Primary immunodeficiency"	3	-0.11838	0.66593	0.95057	0.11838	0.33407	0.99471	-10.048	0.89931	0.99974	1	-8.2095	0.91873	0.99951	2	-6.5011	0.69293	0.86525
"213"	"Prion diseases"	21	-0.021967	0.38684	0.95057	0.021967	0.61316	0.99471	-18.784	0.78532	0.99974	7	-11.586	0.72675	0.99951	14	-14.813	0.7655	0.89458
"214"	"Progesterone-mediated oocyte maturation"	25	-0.21222	0.71912	0.96956	0.21222	0.28088	0.99471	-19.714	0.73675	0.99974	14	-17.058	0.84187	0.99951	11	-10.475	0.39408	0.65702
"215"	"Prolactin signaling pathway"	24	-0.0071092	0.36179	0.95057	0.0071092	0.63821	0.99471	-18.843	0.71094	0.99974	17	-18.171	0.81678	0.99951	7	-6.5738	0.22465	0.54195
"216"	"Propanoate metabolism"	29	0.095027	0.18851	0.76219	-0.095027	0.81149	1	-13.018	0.028262	0.28733	18	-8.355	0.009816	0.32181	11	-10.45	0.39097	0.65702
"217"	"Prostate cancer"	30	-0.089989	0.50002	0.95057	0.089989	0.49998	0.99471	-24.593	0.95591	0.99974	18	-21.307	0.95347	0.99951	12	-12.79	0.6316	0.83621
"218"	"Proteasome"	39	-0.14318	0.54061	0.95057	0.14318	0.45939	0.99471	-11.772	0.00034337	0.017454	13	-6.9298	0.020152	0.35306	26	-9.5181	0.0082292	0.27248
"219"	"Protein digestion and absorption"	26	-0.054042	0.4195	0.95057	0.054042	0.5805	0.99471	-13.136	0.056787	0.35124	10	-8.6428	0.15859	0.68952	16	-9.9126	0.12154	0.48934
"220"	"Protein export"	14	-0.46217	0.96688	1	0.46217	0.033116	0.43915	-7.8428	0.047878	0.35124	4	-2.7598	0.076681	0.50806	10	-7.5343	0.15683	0.51356
"221"	"Protein processing in endoplasmic reticulum"	97	-0.097787	0.35876	0.95057	0.097787	0.64124	0.99471	-30.294	0.080234	0.38237	48	-21.316	0.084812	0.50806	49	-21.525	0.23931	0.54438
"222"	"Proteoglycans in cancer"	83	-0.24673	0.64512	0.95057	0.24673	0.35488	0.99471	-28.196	0.095734	0.41713	41	-25.853	0.72389	0.99951	42	-14.093	0.003456	0.17165
"223"	"Proximal tubule bicarbonate reclamation"	10	-0.66123	0.99767	1	0.66123	0.0023255	0.058923	-5.9415	0.050948	0.35124	4	-6.1316	0.35406	0.89417	6	-2.6641	0.039206	0.38113
"224"	"Purine metabolism"	56	-0.33309	0.82503	1	0.33309	0.17497	0.84709	-22.644	0.11169	0.45253	23	-13.443	0.079282	0.50806	33	-18.274	0.37069	0.646
"225"	"Pyrimidine metabolism"	28	-0.35199	0.89453	1	0.35199	0.10547	0.71484	-22.649	0.8835	0.99974	11	-14.735	0.76052	0.99951	17	-17.214	0.86065	0.97149
"226"	"Pyruvate metabolism"	34	0.01911	0.28585	0.92515	-0.01911	0.71415	1	-14.306	0.025267	0.27523	17	-9.7103	0.04266	0.40546	17	-10.521	0.14147	0.48934
"227"	"RIG-I-like receptor signaling pathway"	21	0.081567	0.22157	0.79506	-0.081567	0.77843	1	-21.779	0.95692	0.99974	11	-16.027	0.86514	0.99951	10	-14.751	0.89734	0.97716
"228"	"RNA degradation"	36	-0.078389	0.43672	0.95057	0.078389	0.56328	0.99471	-24.36	0.84101	0.99974	19	-18.837	0.79082	0.99951	17	-15.535	0.70614	0.87629
"229"	"RNA polymerase"	9	0.13582	0.19742	0.76219	-0.13582	0.80258	1	-22.051	0.99974	0.99974	7	-18.798	0.99781	0.99951	2	-11.61	0.98533	0.99064
"230"	"RNA transport"	92	0.32394	0.0082195	0.17907	-0.32394	0.99178	1	-31.204	0.21784	0.6205	53	-22.53	0.088063	0.50806	39	-21.662	0.55485	0.78295
"231"	"Rap1 signaling pathway"	52	-0.10739	0.44407	0.95057	0.10739	0.55593	0.99471	-23.814	0.30388	0.69166	24	-19.468	0.65333	0.99951	28	-14.429	0.14286	0.48934
"232"	"Ras signaling pathway"	59	-0.054413	0.34013	0.95057	0.054413	0.65987	0.99471	-31.515	0.92186	0.99974	29	-24.831	0.94632	0.99951	30	-19.783	0.63417	0.83621
"233"	"Regulation of actin cytoskeleton"	97	-0.2799	0.68432	0.95057	0.2799	0.31568	0.99471	-29.98	0.066245	0.35124	43	-23.469	0.39692	0.94634	54	-19.239	0.033388	0.38113
"234"	"Regulation of lipolysis in adipocytes"	16	-0.12445	0.5948	0.95057	0.12445	0.4052	0.99471	-17.596	0.87255	0.99974	9	-17.69	0.98473	0.99951	7	-6.5447	0.22189	0.54195
"235"	"Relaxin signaling pathway"	41	0.17258	0.08773	0.59484	-0.17258	0.91227	1	-21.855	0.41669	0.79432	25	-21.16	0.7974	0.99951	16	-8.535	0.054156	0.41279
"236"	"Renal cell carcinoma"	30	0.20492	0.087034	0.59484	-0.20492	0.91297	1	-15.996	0.14811	0.50755	17	-12.597	0.20455	0.73055	13	-9.8947	0.20085	0.54195
"237"	"Renin secretion"	19	-0.39144	0.92725	1	0.39144	0.072752	0.61121	-12.974	0.20352	0.5856	7	-10.13	0.55946	0.99951	12	-8.5885	0.1736	0.52234
"238"	"Renin-angiotensin system"	11	-0.11473	0.61674	0.95057	0.11473	0.38326	0.99471	-5.9743	0.035053	0.31445	5	-5.9567	0.23551	0.78127	6	-2.6515	0.038868	0.38113
"239"	"Retinol metabolism"	9	-0.34971	0.91728	1	0.34971	0.082722	0.63075	-9.2516	0.32756	0.72396	2	-7.3297	0.74487	0.99951	7	-6.5725	0.22453	0.54195
"240"	"Retrograde endocannabinoid signaling"	61	-0.17153	0.55195	0.95057	0.17153	0.44805	0.99471	-19.571	0.0059181	0.15042	29	-14.153	0.032347	0.40546	32	-13.548	0.037816	0.38113
"241"	"Rheumatoid arthritis"	16	-0.77957	0.99932	1	0.77957	0.00068476	0.029742	-12.739	0.34253	0.73336	5	-9.6992	0.65888	0.99951	11	-8.8241	0.21498	0.54195
"242"	"Riboflavin metabolism"	5	-0.063297	0.5551	0.95057	0.063297	0.4449	0.99471	-5.9992	0.28066	0.67763	4	-6.4537	0.39214	0.94634	1	-0.50714	0.17862	0.52234
"243"	"Ribosome"	111	-0.47607	0.90862	1	0.47607	0.091384	0.66362	-25.7	0.00013974	0.0085239	33	-10.77	0.00049123	0.14737	78	-23.652	0.02027	0.38113
"244"	"Ribosome biogenesis in eukaryotes"	22	0.31618	0.039674	0.39715	-0.31618	0.96033	1	-20.143	0.87159	0.99974	13	-14.423	0.6418	0.99951	9	-14.158	0.90223	0.97716
"245"	"SNARE interactions in vesicular transport"	18	-0.3756	0.92277	1	0.3756	0.077229	0.61325	-18.025	0.83786	0.99974	4	-5.8403	0.32083	0.86711	14	-17.316	0.93782	0.97716
"246"	"Salivary secretion"	22	-0.66904	0.99566	1	0.66904	0.0043426	0.088299	-14.39	0.26099	0.66336	9	-9.0517	0.27135	0.78815	13	-11.189	0.33461	0.61582
"247"	"Salmonella infection"	45	-0.16847	0.56893	0.95057	0.16847	0.43107	0.99471	-18.848	0.067372	0.35124	19	-12.434	0.11689	0.61521	26	-14.166	0.17515	0.52234
"248"	"Selenocompound metabolism"	9	-0.40249	0.94848	1	0.40249	0.051523	0.52381	-4.7496	0.033929	0.31445	5	-4.642	0.13181	0.64128	4	-1.9346	0.071681	0.41693
"249"	"Serotonergic synapse"	26	-0.40841	0.92585	1	0.40841	0.074146	0.61121	-16.369	0.30362	0.69166	10	-13.603	0.69361	0.99951	16	-10.111	0.1348	0.48934
"250"	"Shigellosis"	39	-0.18371	0.61647	0.95057	0.18371	0.38353	0.99471	-21.033	0.35914	0.74192	17	-14.374	0.39189	0.94634	22	-15.369	0.41999	0.68391
"251"	"Signaling pathways regulating pluripotency of stem cells"	19	0.012665	0.34297	0.95057	-0.012665	0.65703	0.99471	-15.848	0.52632	0.92257	12	-14.898	0.73251	0.99951	7	-6.6043	0.22758	0.54195
"252"	"Small cell lung cancer"	34	0.63101	0.00046556	0.027581	-0.63101	0.99953	1	-26.74	0.97895	0.99974	21	-23.995	0.98402	0.99951	13	-12.747	0.52713	0.77765
"253"	"Sphingolipid metabolism"	7	-0.14176	0.68566	0.95057	0.14176	0.31434	0.99471	-16.552	0.9921	0.99974	1	-8.2095	0.91873	0.99951	6	-14.527	0.9777	0.99064
"254"	"Sphingolipid signaling pathway"	45	-0.31361	0.80354	1	0.31361	0.19646	0.86938	-24.956	0.66591	0.99974	22	-21.599	0.90341	0.99951	23	-13.783	0.22806	0.54195
"255"	"Spliceosome"	94	0.85594	1.2089e-06	0.00036871	-0.85594	1	1	-38.81	0.92348	0.99974	73	-32.899	0.64848	0.99951	21	-20.771	0.94975	0.98615
"256"	"Staphylococcus aureus infection"	15	-0.099392	0.54351	0.95057	0.099392	0.45649	0.99471	-14.004	0.53799	0.92704	3	-7.4291	0.63118	0.99951	12	-11.942	0.53138	0.77926
"257"	"Starch and sucrose metabolism"	19	0.066382	0.25732	0.89185	-0.066382	0.74268	1	-10.452	0.053205	0.35124	7	-8.2709	0.33377	0.87835	12	-6.8352	0.070425	0.41693
"258"	"Steroid biosynthesis"	6	-0.10294	0.5916	0.95057	0.10294	0.4084	0.99471	-11.029	0.79117	0.99974	1	-0.67917	0.17222	0.7217	5	-11.778	0.91716	0.97716
"259"	"Steroid hormone biosynthesis"	6	0.5263	0.0057967	0.16073	-0.5263	0.9942	1	-5.1824	0.15226	0.51599	6	-5.1824	0.11675	0.61521	0			
"260"	"Sulfur metabolism"	6	-0.29325	0.8566	1	0.29325	0.1434	0.84134	-2.3692	0.028014	0.28733	2	-1.3141	0.11198	0.61093	4	-1.9724	0.073344	0.41693
"261"	"Sulfur relay system"	6	-0.25038	0.80986	1	0.25038	0.19014	0.86555	-4.7526	0.12265	0.45793	3	-1.8018	0.083454	0.50806	3	-4.9193	0.36115	0.64337
"262"	"Synaptic vesicle cycle"	24	-0.9692	0.99996	1	0.9692	3.9273e-05	0.0029945	-13.176	0.10276	0.43072	4	-7.3213	0.49892	0.99951	20	-11.16	0.088548	0.44724
"263"	"Synthesis and degradation of ketone bodies"	8	0.22582	0.10332	0.60115	-0.22582	0.89668	1	-7.7455	0.24129	0.65127	5	-5.2931	0.17846	0.7217	3	-5.8149	0.46792	0.74431
"264"	"Systemic lupus erythematosus"	22	-0.13008	0.59052	0.95057	0.13008	0.40948	0.99471	-16.025	0.44584	0.81917	8	-11.681	0.64051	0.99951	14	-11.258	0.33361	0.61582
"265"	"T cell receptor signaling pathway"	36	-0.055188	0.39532	0.95057	0.055188	0.60468	0.99471	-21.75	0.57376	0.96581	20	-18.357	0.72123	0.99951	16	-12.101	0.31898	0.60933
"266"	"TGF-beta signaling pathway"	15	0.11165	0.19697	0.76219	-0.11165	0.80303	1	-14.728	0.62844	0.99974	8	-11.141	0.5756	0.99951	7	-9.6487	0.58816	0.81144
"267"	"TNF signaling pathway"	26	-0.057346	0.42552	0.95057	0.057346	0.57448	0.99471	-23.532	0.96808	0.99974	14	-19.822	0.96745	0.99951	12	-13.228	0.68054	0.86197
"268"	"Taste transduction"	2	-0.045255	0.5093	0.95057	0.045255	0.4907	0.99471	-6.9611	0.73934	0.99974	1	-8.2095	0.91873	0.99951	1	-1.6349	0.28668	0.58528
"269"	"Taurine and hypotaurine metabolism"	2	-0.27823	0.82689	1	0.27823	0.17311	0.84709	-6.1636	0.65037	0.99974	1	-8.2095	0.91873	0.99951	1	-0.50714	0.17862	0.52234
"270"	"Terpenoid backbone biosynthesis"	15	-0.040045	0.43598	0.95057	0.040045	0.56402	0.99471	-15.088	0.67121	0.99974	8	-12.109	0.68929	0.99951	7	-9.1413	0.5244	0.77746
"271"	"Th1 and Th2 cell differentiation"	22	-0.14758	0.62044	0.95057	0.14758	0.37956	0.99471	-16.967	0.56138	0.95654	12	-11.511	0.32656	0.8747	10	-12.556	0.71737	0.88041
"272"	"Th17 cell differentiation"	28	-0.12985	0.57118	0.95057	0.12985	0.42882	0.99471	-18.064	0.42436	0.80392	17	-13.427	0.28502	0.78815	11	-12.129	0.59969	0.81976
"273"	"Thermogenesis"	132	-0.32339	0.68111	0.95057	0.32339	0.31889	0.99471	-32.248	0.0046615	0.13916	47	-20.907	0.072341	0.50806	85	-24.64	0.017123	0.36448
"274"	"Thiamine metabolism"	7	-0.37836	0.94219	1	0.37836	0.057809	0.551	-5.5241	0.10206	0.43072	2	-6.6977	0.67778	0.99951	5	-2.3003	0.039161	0.38113
"275"	"Thyroid cancer"	11	-0.098818	0.58844	0.95057	0.098818	0.41156	0.99471	-9.7957	0.28187	0.67763	3	-7.0902	0.59156	0.99951	8	-7.1447	0.23083	0.54195
"276"	"Thyroid hormone signaling pathway"	42	-0.35919	0.86582	1	0.35919	0.13418	0.83522	-22.475	0.45537	0.83167	25	-22.308	0.88462	0.99951	17	-8.2746	0.036115	0.38113
"277"	"Thyroid hormone synthesis"	21	-0.58753	0.99012	1	0.58753	0.0098818	0.17729	-10.425	0.036438	0.31754	7	-6.4828	0.16194	0.69402	14	-8.1846	0.07667	0.41693
"278"	"Tight junction"	80	0.057327	0.15025	0.66435	-0.057327	0.84975	1	-33.358	0.70154	0.99974	37	-22.382	0.47509	0.98978	43	-24.738	0.81536	0.93453
"279"	"Toll-like receptor signaling pathway"	29	-0.18438	0.65533	0.95057	0.18438	0.34467	0.99471	-22.8	0.87628	0.99974	17	-20.934	0.96081	0.99951	12	-10.527	0.3627	0.64337
"280"	"Toxoplasmosis"	41	0.20646	0.065585	0.53284	-0.20646	0.93441	1	-21.277	0.34765	0.73634	23	-17.523	0.45112	0.98785	18	-12.304	0.27011	0.57087
"281"	"Transcriptional misregulation in cancer"	23	-0.29288	0.84001	1	0.29288	0.15999	0.84134	-27.652	0.99958	0.99974	11	-21.213	0.99645	0.99951	12	-17.972	0.97195	0.99064
"282"	"Tryptophan metabolism"	21	0.2047	0.090618	0.59484	-0.2047	0.90938	1	-10.333	0.034218	0.31445	11	-5.9418	0.023537	0.35306	10	-8.7424	0.26537	0.56487
"283"	"Tuberculosis"	54	-0.56421	0.98273	1	0.56421	0.017268	0.27719	-25.828	0.48293	0.86137	24	-18.911	0.58834	0.99951	30	-17.738	0.3773	0.65329
"284"	"Type I diabetes mellitus"	5	0.26369	0.089927	0.59484	-0.26369	0.91007	1	-9.3638	0.67036	0.99974	4	-6.3643	0.38145	0.94396	1	-8.2095	0.93587	0.97716
"285"	"Type II diabetes mellitus"	18	0.33392	0.028746	0.32897	-0.33392	0.97125	1	-16.21	0.65464	0.99974	12	-13.932	0.62373	0.99951	6	-8.3729	0.52134	0.77746
"286"	"Tyrosine metabolism"	13	0.023469	0.36315	0.95057	-0.023469	0.63685	0.99471	-7.8239	0.057898	0.35124	5	-5.8967	0.22997	0.78127	8	-5.3118	0.091321	0.45356
"287"	"Ubiquinone and other terpenoid-quinone biosynthesis"	6	-0.23422	0.79006	1	0.23422	0.20994	0.87716	-8.7125	0.53288	0.92704	3	-10.225	0.88264	0.99951	3	-2.0959	0.11085	0.48934
"288"	"Ubiquitin mediated proteolysis"	51	0.26935	0.029122	0.32897	-0.26935	0.97088	1	-29.638	0.91638	0.99974	23	-17.166	0.40693	0.94634	28	-24.441	0.98533	0.99064
"289"	"VEGF signaling pathway"	28	-0.10774	0.52898	0.95057	0.10774	0.47102	0.99471	-17.317	0.33859	0.73336	16	-17.304	0.78001	0.99951	12	-6.4716	0.056704	0.41279
"290"	"Valine, leucine and isoleucine degradation"	41	0.30272	0.025656	0.32804	-0.30272	0.97434	1	-13.799	0.0030773	0.11732	27	-10.418	0.0031513	0.19725	14	-9.1463	0.1323	0.48934
"291"	"Vascular smooth muscle contraction"	40	-0.24066	0.7241	0.96956	0.24066	0.2759	0.99471	-18.565	0.12121	0.45793	13	-11.443	0.27532	0.78815	27	-14.657	0.16972	0.52234
"292"	"Vasopressin-regulated water reabsorption"	22	-0.77594	0.99903	1	0.77594	0.0009699	0.032869	-10.027	0.02351	0.27338	5	-9.2691	0.61008	0.99951	17	-6.3792	0.0080089	0.27248
"293"	"Vibrio cholerae infection"	21	-0.7417	0.99883	1	0.7417	0.0011651	0.035537	-11.174	0.059128	0.35124	7	-8.9816	0.41756	0.9636	14	-7.3346	0.044214	0.38752
"294"	"Viral carcinogenesis"	66	0.21417	0.045436	0.43273	-0.21417	0.95456	1	-28.584	0.47661	0.85509	34	-20.921	0.38388	0.94396	32	-19.485	0.53977	0.78295
"295"	"Viral myocarditis"	25	0.4134	0.010854	0.22069	-0.4134	0.98915	1	-13.887	0.11898	0.45793	19	-10.577	0.038292	0.40546	6	-9.5255	0.66263	0.85615
"296"	"Vitamin B6 metabolism"	3	-0.08076	0.59543	0.95057	0.08076	0.40457	0.99471	-3.0519	0.16852	0.51917	2	-3.0418	0.24897	0.78815	1	-0.98438	0.22085	0.54195
"297"	"Vitamin digestion and absorption"	5	-0.13483	0.67806	0.95057	0.13483	0.32194	0.99471	-6.4017	0.32325	0.71964	3	-6.8861	0.56721	0.99951	2	-1.6882	0.14155	0.48934
"298"	"Wnt signaling pathway"	37	-0.031627	0.3597	0.95057	0.031627	0.6403	0.99471	-20.863	0.43418	0.81146	21	-15.689	0.31654	0.8633	16	-13.753	0.52202	0.77746
"299"	"alpha-Linolenic acid metabolism"	4	-0.19503	0.76861	1	0.19503	0.23139	0.941	-9.2554	0.74099	0.99974	1	-8.2095	0.91873	0.99951	3	-5.9475	0.48412	0.75802
"300"	"beta-Alanine metabolism"	18	0.44201	0.0080666	0.17907	-0.44201	0.99193	1	-10.351	0.06687	0.35124	15	-8.6343	0.03916	0.40546	3	-6.0478	0.49639	0.76256
"301"	"cAMP signaling pathway"	56	-0.20757	0.63204	0.95057	0.20757	0.36796	0.99471	-23.344	0.16026	0.51809	27	-17.119	0.25767	0.78815	29	-15.922	0.21855	0.54195
"302"	"cGMP-PKG signaling pathway"	56	-0.49604	0.9564	1	0.49604	0.043604	0.52381	-19.387	0.011926	0.21397	24	-15.417	0.19796	0.72436	32	-12.295	0.014905	0.36448
"303"	"mRNA surveillance pathway"	43	0.30714	0.022975	0.32333	-0.30714	0.97702	1	-26.338	0.84485	0.99974	31	-22.427	0.69584	0.99951	12	-13.811	0.74098	0.88761
"304"	"mTOR signaling pathway"	59	-0.87448	0.99971	1	0.87448	0.00028502	0.015957	-26.963	0.47429	0.85509	27	-26.443	0.98763	0.99951	32	-12.321	0.015223	0.36448
"305"	"p53 signaling pathway"	11	0.11006	0.22968	0.81456	-0.11006	0.77032	1	-15.064	0.86948	0.99974	6	-11.673	0.79462	0.99951	5	-9.5572	0.74178	0.88761
